<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
	xmlns:media="http://search.yahoo.com/mrss/"
	>
<channel>
	<title>Comments on: Towards the Pharma-Industrial Complex?</title>
	<atom:link href="http://www.brunoandtheprofessor.com/2009/02/towards_the_pharma-industrial_complex.php/feed" rel="self" type="application/rss+xml" />
	<link>http://www.brunoandtheprofessor.com/2009/02/towards_the_pharma-industrial_complex.php</link>
	<description>Bruno and the Professor is a progressive, liberal weekly talk radio podcast covering issues from Seattle, the United States, and the World</description>
	<lastBuildDate>Sat, 28 Jan 2012 01:48:19 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
	<item>
		<title>By: Matski</title>
		<link>http://www.brunoandtheprofessor.com/2009/02/towards_the_pharma-industrial_complex.php/comment-page-1#comment-81901</link>
		<dc:creator>Matski</dc:creator>
		<pubDate>Tue, 24 Feb 2009 18:05:18 +0000</pubDate>
		<guid isPermaLink="false">http://www.brunoandtheprofessor.com/?p=3171#comment-81901</guid>
		<description>Hahahaha ... good point.

A big difference is that Big Pharma still has an international market.  You wouldn&#039;t sell an MX missile to the Soviets, but you&#039;d sell a cancer treatment to the Russians.  

The main reason why I could see this working is that the single payer would define the market priorities.  So, potentially, you could create some kind of a &quot;research priorities&quot; board that would identify a hot list of diseases that needed a treatment.  They&#039;d then create an incentive package to get companies to work on those treatments.  This solves a big problem in the current industry -- namely, that companies only really have an incentive to work on treatments for &quot;mass market&quot; afflictions ... it&#039;s how you get 3 pills for ED, but limited R&amp;D for conditions that afflict smaller numbers of people.</description>
		<content:encoded><![CDATA[<p>Hahahaha &#8230; good point.</p>
<p>A big difference is that Big Pharma still has an international market.  You wouldn&#8217;t sell an MX missile to the Soviets, but you&#8217;d sell a cancer treatment to the Russians.  </p>
<p>The main reason why I could see this working is that the single payer would define the market priorities.  So, potentially, you could create some kind of a &#8220;research priorities&#8221; board that would identify a hot list of diseases that needed a treatment.  They&#8217;d then create an incentive package to get companies to work on those treatments.  This solves a big problem in the current industry &#8212; namely, that companies only really have an incentive to work on treatments for &#8220;mass market&#8221; afflictions &#8230; it&#8217;s how you get 3 pills for ED, but limited R&#038;D for conditions that afflict smaller numbers of people.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Bruno</title>
		<link>http://www.brunoandtheprofessor.com/2009/02/towards_the_pharma-industrial_complex.php/comment-page-1#comment-81545</link>
		<dc:creator>Bruno</dc:creator>
		<pubDate>Tue, 24 Feb 2009 05:51:12 +0000</pubDate>
		<guid isPermaLink="false">http://www.brunoandtheprofessor.com/?p=3171#comment-81545</guid>
		<description>very interesting.  So much defense spending is driven by congressmen&#039;s desire for pork in their district.  I wonder what the relative procurement competitions would be.  Would congressmen with biotech research facilities in their district angle for contracts?  Would the contracting process become so complex that a few companies would make it their core competency and devour everyone else?  

Of course, this hasn&#039;t happened in europe. but they don&#039;t have quite the appetite for government-sponsored corruption that we do. :)</description>
		<content:encoded><![CDATA[<p>very interesting.  So much defense spending is driven by congressmen&#8217;s desire for pork in their district.  I wonder what the relative procurement competitions would be.  Would congressmen with biotech research facilities in their district angle for contracts?  Would the contracting process become so complex that a few companies would make it their core competency and devour everyone else?  </p>
<p>Of course, this hasn&#8217;t happened in europe. but they don&#8217;t have quite the appetite for government-sponsored corruption that we do. <img src='http://www.brunoandtheprofessor.com/wp-includes/images/smilies/icon_smile.gif' alt=':)' class='wp-smiley' /> </p>
]]></content:encoded>
	</item>
</channel>
</rss>

